UBS OCONNOR LLC - FOAMIX PHARMACEUTICALS LTD ownership

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of FOAMIX PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2018$274,000,000
-53.0%
76,454
-24.9%
0.01%
-23.1%
Q3 2018$583,000,000
+293.9%
101,800
+239.3%
0.01%
+550.0%
Q1 2017$148,000,00030,0000.00%
Other shareholders
FOAMIX PHARMACEUTICALS LTD shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 4,781,708$24,530,000,0003.64%
Opaleye Management Inc. 950,000$4,873,0001.39%
DSC Advisors, L.P. 1,187,604$6,092,0001.28%
DAFNA Capital Management LLC 335,500$1,721,0000.84%
Vivo Capital, LLC 855,000$4,386,0000.62%
Stonepine Capital Management, LLC 129,756$666,0000.36%
Eversept Partners, LP 107,500$551,4750.26%
Tekla Capital Management LLC 930,398$4,773,0000.19%
Perceptive Advisors 1,117,324$5,732,0000.16%
Crestline Management, LP 217,670$1,117,0000.14%
View complete list of FOAMIX PHARMACEUTICALS LTD shareholders